Research design and methods of quantitative synthesis of medical evidence

Obstetrics and Gynecology

Volumn 90, Issue 3, 1997, Pages 473-478

  Peipert, Jeffrey F ^a   Gifford, Deidre S ^a   Boardman, Lori A ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMETRY; CASE CONTROL STUDY; COHORT ANALYSIS; DATA ANALYSIS; EPIDEMIOLOGICAL DATA; HEALTH CARE; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; META ANALYSIS; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0030745444     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00305-0     Document Type: Review

References (23)

1. Grimes DA. Teaching evidence-based medicine in obstetrics and gynecology. Obstet Gynecol. 86:1995;451-457.
2. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams and Wilkins, 1996:862.
3. Hulley SB, Cummings SR. Designing clinical research An epidemiologic approach . 1988;Williams and Wilkins, Baltimore.
4. Lucan MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 333:1996;210-215.
5. Peipert JF, Metheny WP, Schulz K. Sample size and power in reproductive research. Obstet Gynecol. 86:1995;302-305.
6. Grimes DA. Randomized controlled trials "It ain't necessarily so." Obstet Gynecol. 78:1991;703-704.
7. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 272:1994;125-128.
8. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias Dimensions of methodologic quality associated with estimates of treatment effects in controlled trials . JAMA. 273:1995;408-412.
9. Grimes DA, Schulz KF. Randomized controlled trials of home uterine activity monitoring A review and critique . Obstet Gynecol. 79:1992;137-142.
10. Last JM. A dictionary of epidemiology. 3rd ed. 1995;52 Oxford University Press, New York.
11. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, Rosner B, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med. 335:1996;453-461.
12. Peipert JF, Grimes DA. The case-control study A primer for the obstetrician-gynecologist . Obstet Gynecol. 84:1994;140-145.
13. Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983;249:1600-4.
14. Lewis MA, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer WO. The increased risk of venous thromboembolism and the use of third generation progestagens Role of bias in observational research . Contraception. 54:1996;5-13.
15. Peipert JF, Sweeney PJ. Diagnostic testing in obstetrics and gynecology A clinician's guide . Obstet Gynecol. 82:1993;619-623.
16. Caillouette JC, Koehler AL. Phasic contraceptive pills and functional ovarian cysts. Am J Obstet Gynecol. 156:1987;1538-1542.
17. Grimes DA, Godwin AJ, Rubin A, Smith JA, Lacarra M. Ovulation and follicular development associated with three low-dose oral contraceptives A randomized controlled trial . Obstet Gynecol. 83:1994;29-34.
18. Chalmers I, Enkin M, Keith MJNC. Effective care in pregnancy and childbirth. 1989;Oxford University Press, Oxford.
19. Longnecker MP, Berlin JA, Orza MJ, Chalmers TC. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 260:1988;652-656.
20. Peipert JF, Bracken MB. Systematic reviews of medical evidence The use of meta-analysis in obstetrics and gynecology . Obstet Gynecol. 89:1997;628-633.
21. Pettiti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis Methods for quantitative synthesis in medicine . 1994;5-6 Oxford University Press, New York.
22. Gifford DS, Keeler E, Kahn KL. Reductions in cost and cesarean rate by routine use of external cephalic version A decision analysis . Obstet Gynecol. 85:1995;930-936.
23. Lieu TA, Watson SE, Washington AE. The cost-effectiveness of prenatal carrier screening for cystic fibrosis. Obstet Gynecol. 84:1994;903-912.